Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Inventory (2016 - 2026)

Iradimed has reported Inventory over the past 14 years, most recently at $11.9 million for Q1 2026.

  • Quarterly Inventory rose 7.77% to $11.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Mar 2026, up 7.77% year-over-year, with the annual reading at $11.6 million for FY2025, 11.71% up from the prior year.
  • Inventory was $11.9 million for Q1 2026 at Iradimed, up from $11.6 million in the prior quarter.
  • Over five years, Inventory peaked at $12.8 million in Q4 2023 and troughed at $4.3 million in Q1 2022.
  • The 5-year median for Inventory is $11.3 million (2024), against an average of $9.7 million.
  • Year-over-year, Inventory surged 138.79% in 2023 and then decreased 18.87% in 2024.
  • A 5-year view of Inventory shows it stood at $5.4 million in 2022, then surged by 138.79% to $12.8 million in 2023, then decreased by 18.87% to $10.4 million in 2024, then increased by 11.71% to $11.6 million in 2025, then increased by 2.26% to $11.9 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Inventory are $11.9 million (Q1 2026), $11.6 million (Q4 2025), and $12.3 million (Q3 2025).